Ebitda Cambiamento Data
AbbVie USD 5.37B 1.85B 2025-12
Aena EUR 661.06M 1.27B 2026-03
Alcon AG USD 317M 337M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 1.97B 457M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BMW EUR 4.61B 236M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
J&J USD 7.19B 2.32B 2025-12
Lonza CHF 1.01B 54M 2025-12
Mercedes-Benz AG EUR 3.57B 1.01B 2025-12
Merck EUR 1.44B 263M 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Novo Nordisk DKK 37.3B 5.86B 2025-12
Orion EUR 130.4M 212.6M 2026-03
Pfizer USD 6.08B 351M 2025-09
Philips EUR 738M 9M 2025-09
Recordati EUR 247.15M 421K 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Sanofi EUR 5.66B 3.77B 2025-09
SAP EUR 3.17B 606M 2026-03
UCB EUR 1.6B 570M 2025-12
Vinci EUR 7.83B 1.7B 2025-12
Volkswagen EUR 11.15B 4.76B 2026-03